|1.||Kim, Eok-Cheon: 1 article (12/2014)|
|2.||Kim, Wan-Joong: 1 article (12/2014)|
|3.||Kim, Tack-Joong: 1 article (12/2014)|
|4.||Song, Min-Cheol: 1 article (12/2014)|
|5.||Park, So-Jung: 1 article (08/2014)|
|6.||Park, Sora: 1 article (08/2014)|
|7.||Yin, Hu-Quan: 1 article (08/2014)|
|8.||Shin, Kye Jung: 1 article (08/2014)|
|9.||Choi, You-Jin: 1 article (08/2014)|
|10.||Park, Hyun-Ju: 1 article (08/2014)|
|2.||Vascular Diseases (Vascular Disease)
08/15/2014 - "MDGA significantly attenuated hepatic neutral lipid accumulation in T0901317- and high fat diet (HFD)-induced fatty liver. "
08/15/2014 - "In the present study, we evaluated the effects of meso-dihydroguaiaretic acid (MDGA) on LXRα activation and its ability to attenuate fatty liver in mice. "
11/01/2013 - "Pain and fatigue responders had greater improvements on SF-36v2 scores (bodily pain, physical functioning, social functioning, PCS), patient global health assessment NRS, and MDGA than nonresponders. "
11/01/2013 - "Measures included patient-reported Medical Outcome Study Short Form-36 Survey, Version 2 (SF-36v2), Fatigue Severity Scale, and numeric rating scales (NRS) for pain and global health assessment and clinician-reported global assessment of disease activity (MDGA). "
10/01/2009 - "PGA, MDGA, HAQ, and VAS Pain, VAS Fatigue, and VAS Sleep all showed good to excellent test-retest reliability in RA. "
10/01/2009 - "Test-retest reliability was 0.702 for PGA, 0.961 for MDGA, and 0.897 for HAQ; VAS results were 0.742 for Pain, 0.741 for Fatigue, and 0.800 for Sleep. "
|2.||Prostaglandins A (PGA)
|1.||Angioplasty (Angioplasty, Transluminal)